🔎 Trials Near Me

Dachaigh › Easbhaidh Alpha-1 Antitrypsin › South Carolina › Charleston

Sgrùdaidhean clionaigeach Easbhaidh Alpha-1 Antitrypsin ann an Charleston, SC

Tha 6 sgrùdaidhean airson Easbhaidh Alpha-1 Antitrypsin a’ lorg phàirtichean aig làraichean ann agus timcheall air Charleston (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.

Teacsa sgrùdaidh oifigeil (Beurla)

A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →

A Study to Evaluate the Safety and Efficacy of BEAM-302 in Adult Patients With Alpha-1 Antitrypsin Deficiency (AATD)

A’ fastadhÌre 1/2
  • Clinical Study Center, Charleston
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 5 Dàmh 2026 · NCT06389877

A Study of TSRA-196 in Adults With PiZZ Alpha-1 Antitrypsin Deficiency (AATD)

A’ fastadhÌre 1/2
  • Clinical Study Center, Charleston
Aoisean 18 gu 70 · Gach gnè · Air ùrachadh 24 Sult 2026 · NCT07227207

A Study in Adults to Learn About Inherited Alpha-1 Antitrypsin Deficiency (AATD) and AATD Related Liver Problems

A’ fastadhSgrùdadh amharc
  • University of South Carolina, Charleston
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 24 Iuch 2026 · NCT06512454

Study to Check the Safety of Fazirsiran and Learn if Fazirsiran Can Help People With Liver Disease and Scarring (Fibrosis) Due to an Abnormal Version of Alpha-1 Antitrypsin Protein

A’ fastadhÌre 3
  • Medical University of South Carolina, Charleston
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 13 Cèit 2026 · NCT05677971

A Study of KB408 for the Treatment of Alpha-1 Antitrypsin Deficiency

A’ fastadhÌre 1
  • Medical University of South Carolina, Charleston
Aoisean 18 gu 70 · Gach gnè · Air ùrachadh 22 Iuch 2025 · NCT06049082

Sgrùdaidhean Easbhaidh Alpha-1 Antitrypsin ann am bailtean eile

Sgrùdaidhean eile ann an Charleston

Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.